(Q53081281)

http://europepmc.org/abstract/MED/25412843

11 May 2018

title

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors. (English)

1 reference

http://europepmc.org/abstract/MED/25412843

11 May 2018

author

Alexander J. Lazar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Judith Bovée

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Makoto Endo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marieke A de Graaff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Davis R Ingram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Simin Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Dina C Lev

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Inge H Briaire-de Bruijn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Neeta Somaiah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Torsten O Nielsen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

21 November 2014

1 reference

http://europepmc.org/abstract/MED/25412843

11 May 2018

published in

Modern Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

587-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2014.155

9 June 2020

exact match

0 references

cites work

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Activating transcription factor 2 in mesenchymal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.155

Histone deacetylase 1 and 2 in mesenchymal tumors

21 January 2018

1 reference

12 December 2020

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.

1 reference

12 December 2020

Nuclear beta-catenin in mesenchymal tumors

1 reference

12 December 2020

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas

1 reference

12 December 2020

Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma

1 reference

12 December 2020

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

1 reference

12 December 2020

10.1038/MODPATHOL.2014.155

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412843%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference